These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 17717819)

  • 1. [Advances of targeted therapy in treatment of hematologic malignancies].
    Huang H; Cao WJ
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2007 Jul; 36(4):313-8. PubMed ID: 17717819
    [No Abstract]   [Full Text] [Related]  

  • 2. Decade in review-haematological cancer: advances in biology and therapy.
    Rajkumar SV; Moreau P
    Nat Rev Clin Oncol; 2014 Nov; 11(11):628-30. PubMed ID: 25311345
    [No Abstract]   [Full Text] [Related]  

  • 3. Advances in the treatment for haematological malignancies.
    Piccaluga PP; Martinelli G; Baccarani M
    Expert Opin Pharmacother; 2006 Apr; 7(6):721-32. PubMed ID: 16556088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor lysis syndrome in the era of novel and targeted agents in patients with hematologic malignancies: a systematic review.
    Howard SC; Trifilio S; Gregory TK; Baxter N; McBride A
    Ann Hematol; 2016 Mar; 95(4):563-73. PubMed ID: 26758269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New targets for hematologic malignancies.
    Bradner J
    Clin Adv Hematol Oncol; 2013 Jun; 11(6):375-6. PubMed ID: 24472807
    [No Abstract]   [Full Text] [Related]  

  • 6. Targeted therapy for haematological malignancies: clinical update from the American Society of Hematology, 2004.
    Haas M; Lonial S
    Expert Opin Investig Drugs; 2005 Sep; 14(9):1161-9. PubMed ID: 16144500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted therapy for hematologic malignancies.
    Kuriakose P
    Cancer Control; 2005 Apr; 12(2):82-90. PubMed ID: 15855891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibodies as targeted therapy in hematologic malignancies in older adults.
    Rao AV; Schmader K
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):247-62. PubMed ID: 17996665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigational antibody-drug conjugates for hematological malignancies.
    Polson AG; Ho WY; Ramakrishnan V
    Expert Opin Investig Drugs; 2011 Jan; 20(1):75-85. PubMed ID: 21142808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New and emerging drug targets for the treatment of hematological malignancies.
    Bendall LJ
    Curr Drug Targets; 2010 Jul; 11(7):767-8. PubMed ID: 20370651
    [No Abstract]   [Full Text] [Related]  

  • 11. New perspectives in the treatment of hematological malignancies.
    Kizaki M
    Curr Pharm Biotechnol; 2006 Oct; 7(5):313. PubMed ID: 17076646
    [No Abstract]   [Full Text] [Related]  

  • 12. [Targeted therapy in the treatment of solid tumors and in hematology-oncology. Advances and disappointments].
    Jochims C; Mazitschek U; Jäger D; Goldschmidt H
    Internist (Berl); 2006 Jun; 47(6):633-41. PubMed ID: 16767478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug resistance in hematologic malignancies.
    Dalton W
    Clin Adv Hematol Oncol; 2005 Apr; 3(4):267-8. PubMed ID: 16166998
    [No Abstract]   [Full Text] [Related]  

  • 14. Nucleoside analogue delivery systems in cancer therapy.
    Diab R; Degobert G; Hamoudeh M; Dumontet C; Fessi H
    Expert Opin Drug Deliv; 2007 Sep; 4(5):513-31. PubMed ID: 17880274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Editorial: Innovative therapeutical approaches for hematological malignancies based on molecular targeted therapies.
    Zauli G
    Curr Pharm Des; 2008; 14(21):2022. PubMed ID: 18691112
    [No Abstract]   [Full Text] [Related]  

  • 16. Targeted and tailored therapy in hemato-oncology: vision for the 21st century.
    Shpilberg O; Ben-Bassat I; Raanani P
    Isr Med Assoc J; 2006 Dec; 8(12):843-4. PubMed ID: 17214100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting MDM4 as a Novel Therapeutic Approach for Hematologic Malignancies.
    Cao L; Fan L; Xu W; Li JY
    Curr Cancer Drug Targets; 2015; 15(9):769-80. PubMed ID: 26567881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in the treatment of haematological malignancies: optimal sequence of CML treatment.
    Hochhaus A
    Ann Oncol; 2007 Jul; 18 Suppl 9():ix58-63. PubMed ID: 17631597
    [No Abstract]   [Full Text] [Related]  

  • 19. Bendamustine: a new therapeutic option for hematologic malignancies.
    Cheson BD
    Clin Adv Hematol Oncol; 2008 Sep; 6(9):631-3. PubMed ID: 18827785
    [No Abstract]   [Full Text] [Related]  

  • 20. Targeted Drug Delivery for the Treatment of Blood Cancers.
    Jiang Y; Lin W; Zhu L
    Molecules; 2022 Feb; 27(4):. PubMed ID: 35209102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.